| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.004 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.004 |